The theme for last month’s startup pitch night co-hosted by Startup Vic and LaunchVic was Health Tech and Med Tech. According to recent data, of Victoria’s 2,700 startups, 20% are in health services and technology. The judging panel was drawn from HealthKit, ANDHealth, MHX and Pfizer.
With the vision of “making custom-fit the new norm”, Hearables 3d is developing personalised and customisable ear devices. In many cases, users give up on hearing aids because the purchase process is slow (it can take 2 weeks to place an order), expensive (average price of $300), and often of variable quality. Plus, providers are relatively inaccessible. Instead, using a combination of smartphone scanning, design powered by machine-learning and a 3D production process, Hearables 3d aims to get costs down to $50.
The team are already developing working prototypes, running user trials, filing a patent, setting up a B2B distribution pilot, and have recently raised seed equity and been admitted to the Skalata Ventures accelerator programme. This will be followed by further fundraising in 6-9 months’ time.
The judges were interested to understand more about the business model – especially the payment system, and distribution structure. Hearables 3d aims to be a service provider to existing distributors, leveraging their automated design process. Given that the medical device registration process is currently done by manufacturers, of which there a six global firms, it would appear to make sense to become embedded in the current manufacturing eco-system and a key aspect of the go-to-market strategy..
The team is also looking at other verticals, such as sleep apnea devices, but the judges wanted to understand whether there were any plans for a direct to consumer model, and whether they were actively engaging with audiologists. There was also a suggestion that some competitors were making more of a fashion statement about their products, incorporating elements of jewellery into their designs.
Aiming to “take guesswork out of stent selection”, Stelect is changing the way PCI procedures (Percutaneous Coronary Intervention, formerly known as angioplasty with stent) are conducted. Currently, 4.1m cardiac stents are fitted in patients each year, but according to the founders, more than 70% are incorrectly sized.
Stelect has developed a balloon catheter with spatial sensors, which ensures a more accurate fit and a less invasive procedure because measurement and fitting are done in a single step.
Claiming that competing products are expensive (non-reimbursable), complex, not and integrated to current workflows, the team are initially targeting more acute cases, which account for 15% of procedures.
A previous winner of MedTech’s Got Talent, Stelect is aiming to complete a US FDA 501(k) pre-market submission for new devices by July 2021, with the likely exit of a trade sale once that process is approved.
A key benefit of this device is that it will combine two existing reimbursable codes, resulting in both initial cost savings for patients, plus downstream economic advantages for health service providers. Asked about clinician feedback and potential take-up, especially when compared to current imaging processes, the team stated that by removing the interim step of having to use a separate imaging catheter will significantly reduce the procedure time. The product overcomes the engineering constraints of traditional balloon catheters by drawing on the expertise of a microscopic transducers expert.
As to selling into hospitals, the team plan to partner with existing manufacturers and suppliers, and license the sensory capabilities. And while there is potential to commercialise data & analytics (for predictive purposes, for example) the current focus is on the device.
According to the founders, the completion, collection and management of medical consent forms results in 40% dissatisfaction, just 20% retention and only 9% compliance. Often the cause of legal claims (due to limited patient understanding, poor form design or a lack of clarity), Consentic plan to challenge the status quo using video content, a checklist (to reinforce understanding) and a simplified consent form.
The team already claim a 20% improvement in patient comprehension, 80% patient preference for this model, and a 15% reduction in patient anxiety. It also saves clinician time. The product will be supplied under a subscription model with scale rates, and having completed successful trials in their own field of dermatology, the founders are looking to extend the service to other medical and consent verticals.
The team have completed 40 trials with 10 paid customers, completed the HCF Catalyst accelerator program, and are currently part of the 2019 MHX cohort.
The team were asked about whether they have integrated with practice management software (not yet), and whether they had plans to address US issues on health care and “financial consent”, and for removing the issue of consent as a barrier to clinical trials.
Hayylo is an aged care home services provider. For many clients, services change often with little or no notice. According to the founders, there is little transfer of client knowledge, a lack of shared team processes, and few common tools. Part of the problem is a communication challenge. This all impacts client independence.
Hayylo is an online platform, working with multiple channels and providers. It can provide clients with automatic updates, resulting in call reduction, and increased satisfaction. Using a B2B SaaS model, along with white label options, the team is targeting a potion of the $4bn-$8bn global market.
To date the team has mainly bootstrapped, obtained some angel investment, and has been in market since April 2018. Their strategy is to offer integration solutions (with rostering and practice management tools) and develop distribution partnerships (reseller agreements).
While there is competition, including from AI/ML and IoT solutions, the team believe that by mapping multiple data sources on to a single platform, and by unifying the team experience, the resulting operating system model gives them an edge. Currently in user testing with 10 providers, and 30,000 clients, the team is also using focus groups to gather feedback.
After the audience voting and judges’ diliberations were done, the People’s choice was Stelect, while the overall winner was Consentric.
Next week: Sometimes it’s OK to Meet Your Idols